The page is the record's research on the issuer — no analyst, no rating, no view. # Satellos Bioscience Inc. (NASDAQ: MSLE) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Satellos Bioscience Inc., listed on NASDAQ under the ticker MSLE, with ISIN US80401L8037. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-Z4. The security type is non-operating entity type (other), the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is Canada (Federal Level). The listing status is listed, not halted. ## The disclosure read The record holds 43 filings in the window 2025-11-08 to 2026-11-08, on 33 filing days, comprising 2 prospectus, 9 regulatory filing and 32 results filings. The median gap between filing days is 6.0 days. The latest filing is dated 2026-11-06, a results filing, 2 days before the record date of 2026-11-08. The exchange median cadence gap is 6.0 days, the exchange median filings count is 52, and the exchange median latency is 5.0 days, across 4359 NASDAQ issuers. The sector median cadence gap is 6.0 days, the sector median filings count is 63.0, and the sector median latency is 4.0 days, across 526 issuers in 2834 Pharmaceutical Preparations. ## Auditor The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and foreign private issuers and older filings carry none. The auditor location is not on the record. The record holds no auditor changes. ## Events and halts The record holds two listing lines, dated 2026-02-05 and 2026-02-06. It holds no delisting and no name change. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations pages read. The count is 0. ## Open research No openly published research notes were found on the record. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2022, 2023, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001421642.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/MSLE (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/MSLE (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/MSLE · public-record only · the same page signed and receipted: get_research at https://mcp.getissuer.ai/mcp